The CHMP has recommended approval of Jorveza oral suspension 0.2 mg/mL, the first licensed pediatric formulation of ...

In patients with allergic rhinitis, intranasal budesonide lowers type 2 and neutrophilic marker levels, improves airflow, and ...

IgA nephropathy (IgAN), or Berger’s disease, is a kidney condition that occurs when abnormal immunoglobulin A (IgA) antibodies trigger inflammation in the kidneys. Until recently, treatment for IgAN ...

The lead team of the evaluation committee considered evidence submitted by Genus Pharmaceuticals, a review of this submission by the external assessment group (EAG), and responses from stakeholders.

the highest tolerated licensed dose of renin-angiotensin system inhibitors, or a dual endothelin angiotensin-receptor antagonist. Optimised standard care is standard care that has been personalised to ...

As new trial findings show significant reductions in paediatric asthma attacks from a budesonide-formoterol 2-in-1 reliever therapy, Professor Andy Bush speaks to Saša Janković about the system ...

More common side effects of Tarpeyo (budesonide) include swelling of your hands, legs, ankles, or feet, acne, headache, high blood pressure, and muscle spasms. Tarpeyo can cause side effects that ...

A major new study has provided evidence that treatment for childhood asthma could be significantly improved by replacing traditional salbutamol relievers with budesonide–formoterol. This randomised ...

Findings from a trial comparing the real-world effectiveness of asthma inhalers could reshape how children with asthma are treated. In the first randomized controlled trial to investigate the use of a ...

Severe exacerbation occurred in 5.1% of patients taking albuterol/budesonide compared with 9.1% of patients taking albuterol alone in the on-treatment efficacy population. Albuterol/budesonide ...